Patient Guide: DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemotherapy

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 228 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07472517
Status: NOT_YET_RECRUITING
Condition: Small Cell Lung Cancer (SCLC), Extensive-stage Small Cell Lung Cancer (ES-SCLC)
Phase: PHASE3

Find a Study Location Near You

This study is available at 228 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Mobile, Alabama
  • Little Rock, Arkansas
  • Atlanta, Georgia
  • • And 225 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily